Imperial College London

Mr SRDJAN SASO

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

+44 (0)7890 795 182srdjan.saso01

 
 
//

Location

 

Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Publication Type
Year
to

250 results found

Jones B, L'Heveder A, Bishop C, Kasaven L, Saso S, Davies S, Chakraverty R, Brown J, Pollock Net al., 2024, Menstrual cycles and the impact upon performance in elite British track and field athletes: a longitudinal study, Frontiers in Sports and Active Living, Vol: 6, Pages: 1-8, ISSN: 2624-9367

Objective: To assess the prevalence of menstrual disorders and the perceivedeffect of menstrual cycles upon performance in elite athletes.Methodology: A longitudinal survey in the form of a questionnaire was sent tofemale track and field athletes at British Athletics every 6 months, over afive-year period between 1st October 2014 and 1st October 2019 in theUnited Kingdom (UK).Results: 128 athletes completed an average of 4.2 ± 2.9 questionnaires acrossthe study period. The mean age of menarche was 14.2 ± 1.4 years, 13.4 ± 1.3years and 12.8 ± 1.4 years in endurance, power, and thrower athletesrespectively (p < 0.05). Two-thirds (66%; n = 82) reported consistently regularcycles, 30% (n = 37) irregular at some point during the period of observationand 4% (n = 5) were amenorrhoeic. 87 athletes (68%) reported dysmenorrhoeaand 40 (31%) menorrhagia. More than three quarters (76.8%; n = 96) describedtheir cycle negatively affected performance. Amongst those who reportedwhen the negative impact occurred (n = 91), 40% (n = 36) reported this inthe late luteal phase and 35% (n = 32) during the early follicular phase. 79%(n = 100) of athletes reported at least one cyclical symptom, of which bloating,lower back and pelvic pain were most frequently experienced.Conclusion: This data highlights the complex interrelationship between women’shealth and elite athletic performance. Athletes perceive a negative impact fromtheir menstrual cycles upon performance with a desire to manage these moreeffectively, particularly during competition. Female reproductive healthexpertise in the multi-disciplinary management of elite athletes is required.

Journal article

Barcroft JF, Linton-Reid K, Landolfo C, Al-Memar M, Parker N, Kyriacou C, Munaretto M, Fantauzzi M, Cooper N, Yazbek J, Bharwani N, Lee SR, Kim JH, Timmerman D, Posma J, Savelli L, Saso S, Aboagye EO, Bourne Tet al., 2024, Machine learning and radiomics for segmentation and classification of adnexal masses on ultrasound, NPJ Precis Oncol, Vol: 8, ISSN: 2397-768X

Ultrasound-based models exist to support the classification of adnexal masses but are subjective and rely upon ultrasound expertise. We aimed to develop an end-to-end machine learning (ML) model capable of automating the classification of adnexal masses. In this retrospective study, transvaginal ultrasound scan images with linked diagnoses (ultrasound subjective assessment or histology) were extracted and segmented from Imperial College Healthcare, UK (ICH development dataset; n = 577 masses; 1444 images) and Morgagni-Pierantoni Hospital, Italy (MPH external dataset; n = 184 masses; 476 images). A segmentation and classification model was developed using convolutional neural networks and traditional radiomics features. Dice surface coefficient (DICE) was used to measure segmentation performance and area under the ROC curve (AUC), F1-score and recall for classification performance. The ICH and MPH datasets had a median age of 45 (IQR 35-60) and 48 (IQR 38-57) years old and consisted of 23.1% and 31.5% malignant cases, respectively. The best segmentation model achieved a DICE score of 0.85 ± 0.01, 0.88 ± 0.01 and 0.85 ± 0.01 in the ICH training, ICH validation and MPH test sets. The best classification model achieved a recall of 1.00 and F1-score of 0.88 (AUC:0.93), 0.94 (AUC:0.89) and 0.83 (AUC:0.90) in the ICH training, ICH validation and MPH test sets, respectively. We have developed an end-to-end radiomics-based model capable of adnexal mass segmentation and classification, with a comparable predictive performance (AUC 0.90) to the published performance of expert subjective assessment (gold standard), and current risk models. Further prospective evaluation of the classification performance of this ML model against existing methods is required.

Journal article

Al-Memar M, Fourie H, Vaulet T, Lawson K, Bobdiwala S, Saso S, Farren J, Pipi M, De Moor B, Stalder C, Bennett P, Timmerman D, Bourne Tet al., 2024, Using simple clinical and ultrasound variables to develop a model to predict first trimester pregnancy viability., Eur J Obstet Gynecol Reprod Biol, Vol: 292, Pages: 187-193

INTRODUCTION: Early prediction of pregnancies destined to miscarry will allow couples to prepare for this common but often unexpected eventuality, and clinicians to allocate finite resources. We aimed to develop a prediction model combining clinical, demographic, and sonographic data as a clinical tool to aid counselling about first trimester pregnancy outcome. MATERIAL AND METHODS: This is a prospective, observational cohort study conducted at Queen Charlotte's and Chelsea Hospital, UK from March 2014 to May 2019. Women with confirmed intrauterine pregnancies between 5 weeks and their dating scan (11-14 weeks) were recruited. Participants attended serial ultrasound scans in the first trimester and at each visit recorded symptoms of vaginal bleeding, pelvic pain, nausea and vomiting using validated scoring tools. Pregnancies were followed up until the dating scan (11-14 weeks). Univariate and multivariate analyses were performed to predict first trimester viability. A model was developed with multivariable logistic regression, variables limited by feature selection, and bootstrapping with multiple imputation was used for internal validation. RESULTS: 1403 women were recruited and after exclusions, data were available for 1105. 160 women (14.5 %) experienced first trimester miscarriage and 945 women (85.5 %) had viable pregnancies at 11-14 weeks' gestation. The average gestational age at the initial visit (calculated from the menstrual dates) was 7 + 1 weeks (+/-12.2 days). A multivariable logistic regression model was developed to predict first trimester viability and included the variables: mean gestational sac diameter, presence of fetal heart pulsations, difference in gestational age from last menstrual period and from mean sac diameter on ultrasonography, current folic acid usage and maternal age. The model demonstrated good performance (optimism-corrected area under curve (AUC) 0.84, 95 % CI 0.81-0.87; opti

Journal article

Vali S, Saso S, Bracewell Milnes T, Nicopoullos J, Thum M-Y, Smith JR, Jones BPet al., 2023, The Clinical Application of Platelet-Rich Plasma in the Female Reproductive System: A Narrative Review., Life (Basel), Vol: 13, ISSN: 2075-1729

Platelet-rich plasma is an autologous plasma containing platelets prepared from fresh whole blood drawn from a peripheral vein. Through processing, it can be prepared to contain supraphysiologic levels of platelets at three to five times greater than the level of normal plasma. PRP has been explored both in vivo and ex vivo in the human endometrium model in its ability to harness the intrinsic regenerative capacity of the endometrium. Intrauterine autologous PRP infusions have been shown to increase endometrial thickness and reduce the rate of intrauterine adhesions. In the setting of recurrent implantation failure, intrauterine infusion of PRP has been shown to increase clinical pregnancy rate. PRP also appears to hold a potential role in select patients with premature ovarian insufficiency, poor ovarian responders and in improving outcomes following frozen-thawed transplantation of autologous ovarian tissue. Further studies are required to explore the potential role of PRP in reproductive medicine further, to help standardise PRP protocols and evaluate which routes of administration are most effective.

Journal article

Jones B, Vali S, Kasaven L, Mantrali I, Saso S, Bracewell-Milnes T, Nicopoullos J, Thum M-Y, Diaz-Garcia C, Quiroga I, Yazbek J, Smith JRet al., 2023, INvestigational Study Into Transplantation of the Uterus (INSITU); a cross-sectional survey amongst women with uterine factor infertility in the UK assessing background, motivations and suitability, BMJ Open, Vol: 13, ISSN: 2044-6055

Importance: The study summarises the selection pre-screen criteria currently used in the UK for a uterus transplant and highlights the number of women who are suitable to proceed. Objectives: To assess the demographics, motivations, reasons and suitability amongst women with AUFI to undergo uterus transplantation (UTx). Design: A cross sectional survey Setting: An electronic questionnaire was sent via email to women with AUFI who had previously been referred to the UTx research team or approached the Womb Transplant UK Charity. The questions assessed suitability to undergo UTx based on demographic information, perceptions to adoption and surrogacy and reasons why UTx was preferable. Responses were assessed against the study selection criteria.Participants: Women with AUFI Results: 210 women completed the questionnaire. The most common aetiology of AUFI in our cohort was MRKH (68%; n=143) whereas 29% (n=62) had previously undergone hysterectomy. 63% (n=132) of the cohort had previously considered adoption, 5% (n=11) had attempted it, and two (1%) had successfully adopted. The most common reason cited to undergo UTx over adoption was to experience gestation (n= 63; 53%), while 37% (n=44) wanted a biologically related child. 76% (n=160) of participants had previously considered surrogacy, 22 (10%) had attempted it and two (1%) had successfully become mothers using a surrogate. The most common reason to undergo UTx over surrogacy was to experience gestation (n=77; 54%). 15% n=21) were concerned about the legal implications, 14% (n=20) identified the financial cost as a barrier and 8% (n=12) could not consider it due to religious reasons. On adhering to the selection criteria, 65 (31%) women were suitable to proceed with the trial.Conclusion: The study demonstrates that implementing commonly used selection criteria for a UTx led to an attrition rate of more than two thirds of women who requested to initially undergo the process. As more studies present outcomes followi

Journal article

Kasaven LS, Mitra A, Ostrysz P, Theodorou E, Murugesu S, Yazbek J, Bracewell-Milnes T, Ben Nagi J, Jones BP, Saso Set al., 2023, Exploring the knowledge, attitudes, and perceptions of women of reproductive age towards fertility and elective oocyte cryopreservation for age-related fertility decline in the UK: a cross-sectional survey., Hum Reprod, Vol: 38, Pages: 2478-2488

STUDY QUESTION: What are the knowledge, perceptions and attitudes towards fertility and elective oocyte cryopreservation (OC) for age-related fertility decline (ARFD) in women in the UK? SUMMARY ANSWER: Awareness of OC for ARFD has reportedly improved compared to studies carried out almost a decade ago, but inconsistencies in knowledge remain regarding the rate of miscarriage amongst specific age groups, the financial costs and optimal age to undergo OC for ARFD. WHAT IS KNOWN ALREADY: The age of first-time motherhood has increased amongst western societies, with many women of reproductive age underestimating the impact of age on fertility. Further understanding of women's awareness of their fertility, the options available to preserve it and the barriers for seeking treatment earlier are required in order to prevent the risk of involuntary childlessness. STUDY DESIGN, SIZE, DURATION: A hyperlink to a cross-sectional survey was posted on social media (Instagram) between 25 February 2021 and 11 March 2021. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women from the general population aged 18-50 years were invited to complete the survey. MAIN RESULTS AND THE ROLE OF CHANCE: In total, 5482 women fulfilled the inclusion criteria and completed the survey. The mean age of participants was 35.0 years (SD 10.25; range 16-52). Three quarters (74.1%; n = 4055) disagreed or strongly disagreed they felt well informed regarding the options available to preserve their fertility, in case of a health-related problem or ARFD. The majority overestimated the risk of miscarriage in women aged ≥30 years old, with 14.5% correctly answering 20%, but underestimated the risks in women ≥40, as 20.1% correctly answered 40-50%. Three quarters (73.2%; n = 4007) reported an awareness of OC for ARFD and 65.8% (n = 3605) reported that they would consider undergoing the procedure. The number of women who considered OC for ARFD across

Journal article

Murugesu S, Theodorou E, Kasaven LS, Jones BP, Saso S, Ben-Nagi Jet al., 2023, Intrauterine instillation of human chorionic gonadotropin at the time of blastocyst transfer: Systematic review and meta-analysis, JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, Vol: 52, ISSN: 2468-7847

Journal article

Bergamini A, Ramaswami R, Froeling F, Papanastasopoulos P, Short D, Aguiar X, Savage PM, Sarwar N, Kaur B, Saso S, Fotopoulou C, Sharma A, Rustin GJS, Seckl Met al., 2023, Fertility outcomes following surgery and multiagent chemotherapy in malignant ovarian germ cell tumor survivors: a survey study., Int J Gynecol Cancer, Vol: 33, Pages: 1750-1756

OBJECTIVE: To assess fertility outcomes in long-term survivors of malignant ovarian germ cell tumors treated with fertility-sparing surgery with or without additional chemotherapy. METHODS: Women diagnosed and treated for malignant ovarian germ cell tumors at Charing Cross Hospital or Mount Vernon Cancer Centre between 1977 and 2015 were included. Questionnaires assessing fertility issues were sent to patients treated with fertility-sparing surgery. Fertility outcomes were evaluated according to the treatment received. The effect of the mean total dose of cyclophosphamide and cisplatin was assessed. RESULTS: A total of 146 patients were sent the questionnaire; 77 (56.5%) patients were included in the analysis. A total of 49 (64%) patients received platinum-based chemotherapy after surgery, 39 (79.6%) of these with cisplatin, vincristine, methotrexate, bleomycin, actinomycin D, cyclophosphamide, and etoposide, while 10 (20.4%) with bleomycin, etoposide, and cisplatin. After any treatment, 39/46 patients (85%) became pregnant: the conception rate was not different between those receiving surgery only and those receiving also chemotherapy (85.7% vs 84.4%, p=1.0). Live birth rate was 80.4% (37/46), with no statistically significant difference between the treatment groups (p=0.42). Median age of women achieving conception was 29 years (IQR 26-33). The probability of live birth at 5 years was 48% and 40% for patients in the surgery only and chemotherapy group, respectively (p=0.55). Infertility and miscarriage rates did not differ significantly between the two treatment groups (p=0.30 and p=0.32). The mean doses of cisplatin and cyclophosphamide received by patients failing and achieving conception were not different (p=0.10, p=0.47). CONCLUSIONS: Our results suggest that fertility may not be hampered in patients with malignant ovarian germ cell tumor treated with fertility-sparing surgery or receiving additional chemotherapy.

Journal article

Kasaven LSS, Marcus D, Theodorou E, Jones BPP, Saso S, Naja R, Serhal P, Ben-Nagi Jet al., 2023, Systematic review and meta-analysis: does pre-implantation genetic testing for aneuploidy at the blastocyst stage improve live birth rate?, JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, Vol: 40, Pages: 2297-2316, ISSN: 1058-0468

Journal article

Jones BP, Vali S, Saso S, Devaney A, Bracewell-Milnes T, Nicopoullos J, Thum M-Y, Kaur B, Roufosse C, Stewart V, Bharwani N, Ogbemudia A, Barnardo M, Dimitrov P, Klucniks A, Katz R, Johannesson L, Garcia CD, Udupa V, Friend P, Quiroga I, Smith JRet al., 2023, Living donor uterus transplant in the UK: A case report, BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, ISSN: 1470-0328

Journal article

Vali S, jones B, Saso S, Sheikh S, quiroga I, smith JRet al., 2023, Attitudes, knowledge, and perceptions amongst women toward uterus transplantation and donation in the UK, Frontiers in Medicine, Vol: 10, Pages: 1-9, ISSN: 2296-858X

Objective: To assess the motivations and perceptions of the general public in the United Kingdom toward donating their uterus for Uterus Transplantation after death (UTx).Design: A cross sectional study.Setting: A 32-item electronic questionnaire.Population: One hundred fifty nine females over the age of 16 living in the United Kingdom, consented and took part in the study.Main outcome measures: The motivations and perceptions toward UTx among the general public including the willingness to donate and barriers preventing donation.Results: One hundred fifty nine women completed the questionnaire. The majority had never heard of UTx (n = 107, 71%) and most were not aware the uterus could be donated after death (n = 130, 92%). 43% of the cohort were willing to donate their uterus after death (n = 57). 8% stated they wished to donate their organs but not their uterus (n = 10). 30% of women (n = 42) believed the child born following UTx would have genetic links to the donor. Over half of the respondents (n = 65, 51%) strongly agreed or agreed they would feel joy in the knowledge that donation would lead to bringing a new life into the world. A quarter of respondents strongly agreed or agreed (n = 45, 25%) that the use of their uterus by another woman would feel like an extension of life.Conclusion: The findings indicate a favorable opinion toward UTx and a positive attitude toward donation of the uterus after death among the general public in the United Kingdom. The findings also highlight the need for education around UTx now this therapeutic option is available.

Journal article

Barcroft J, Lebbos C, Linton-Reid K, Landolfo C, Al Memar M, Bharwani N, Parker N, Kyriacou C, Cooper N, Murugesu S, Pikovsky M, Novak A, Bourne T, Kainz B, Saso Set al., 2023, EP.0248 Automated ultrasound feature extraction in adnexal masses, RCOG World Congress 2023, Publisher: Wiley, Pages: 98-98, ISSN: 1470-0328

Conference paper

Murugesu S, Theodorou E, Kasaven L, Jones B, Saso S, Ben-Nagi Jet al., 2023, Human chorionic gonadotropin intrauterine instillation at blastocyst transfer: Systematic review and meta-analysis, Publisher: WILEY, Pages: 204-204, ISSN: 1470-0328

Conference paper

Vali S, Jones B, Sheikh S, Saso S, Quiroga I, Smith JRet al., 2023, How do women in the UK feel about Uterus transplantation and donation?, Publisher: WILEY, Pages: 206-207, ISSN: 1470-0328

Conference paper

Murugesu S, Barcroft J, Elhag B, Cooper N, Novak A, Pikovsky M, Parker N, Stalder C, Saso S, Bourne Tet al., 2023, Telementoring in gynaecology ultrasound: Impact on patient pathway and postgraduate training, Publisher: WILEY, Pages: 216-217, ISSN: 1470-0328

Conference paper

Murugesu S, Grogan R, Meehan H, Bayar E, Kasaven L, Saso S, Joash K, Bourne Tet al., 2023, Telemedicine and the impact on postgraduate obstetrics and gynaecology training, Publisher: WILEY, Pages: 216-216, ISSN: 1470-0328

Conference paper

Kasaven L, Saso S, Barcroft J, Galazis N, Grewal K, Milnes TB, Jones B, Getreu N, Ben Nagi J, Smith R, Yazbek J, Timmerman D, Bourne T, Ghaem-Maghami S, Verbakel Jet al., 2023, An umbrella review of meta-analyses regarding the incidence of female specific malignancies following fertility treatment, Publisher: OXFORD UNIV PRESS, ISSN: 0268-1161

Conference paper

Barcroft J, Pandrich M, Landolfo C, Del Forno S, Parker N, Cooper N, Pikovsky M, Murugesu S, Novak A, Kyriacou C, Al Memar M, Yazbek J, Timmerman D, Saso S, Bourne Tet al., 2023, The classification and management of adnexal masses identified during pregnancy, Publisher: OXFORD UNIV PRESS, ISSN: 0268-1161

Conference paper

Murugesu S, Charalambides MM, Jones BP, Saso S, Faris R, Parikh J, Nicopoullos J, Thum M-Y, Bracewell-Milnes Tet al., 2023, Social egg freezing: Motivations, treatment experiences and the impact of Covid-19-a single-center experience, ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol: 102, Pages: 760-773, ISSN: 0001-6349

Journal article

Jones B, Vali S, Saso S, Bracewell-Milnes T, Nicopoullos J, Thum Y, Diaz-Garcia C, Yazbek J, Quiroga I, Smith Ret al., 2023, INvestigational Study Into Transplantation of the Uterus (INSITU); Deceased donor uterine retrieval, Publisher: WILEY, Pages: 76-76, ISSN: 1470-0328

Conference paper

Murugesu S, Theodorou E, Kasaven L, Jones B, Saso S, Ben-Nagi Jet al., 2023, Human chorionic gonadotropin intrauterine instillation at blastocyst transfer: Systematic review and meta-analysis, Publisher: WILEY, Pages: 204-204, ISSN: 1470-0328

Conference paper

Vali S, Jones B, Sheikh S, Saso S, Quiroga I, Smith JRet al., 2023, How do women in the UK feel about Uterus transplantation and donation?, Publisher: WILEY, Pages: 206-207, ISSN: 1470-0328

Conference paper

Murugesu S, Barcroft J, Elhag B, Cooper N, Novak A, Pikovsky M, Parker N, Stalder C, Saso S, Bourne Tet al., 2023, Telementoring in gynaecology ultrasound: Impact on patient pathway and postgraduate training, Publisher: WILEY, Pages: 216-217, ISSN: 1470-0328

Conference paper

Barcroft J, Lebbos C, Linton-Reid K, Landolfo C, Al Memar M, Bharwani N, Parker N, Kyriacou C, Cooper N, Murugesu S, Pikovsky M, Novak A, Bourne T, Kainz B, Saso Set al., 2023, Automated ultrasound feature extraction in adnexal masses, Publisher: WILEY, Pages: 98-98, ISSN: 1470-0328

Conference paper

Murugesu S, Grogan R, Meehan H, Bayar E, Kasaven L, Saso S, Joash K, Bourne Tet al., 2023, Telemedicine and the impact on postgraduate obstetrics and gynaecology training, Publisher: WILEY, Pages: 216-216, ISSN: 1470-0328

Conference paper

Jones B, Vali S, Saso S, Bracewell-Milnes T, Nicopoullos J, Thum Y, Diaz-Garcia C, Yazbek J, Quiroga I, Smith Ret al., 2023, INvestigational Study Into Transplantation of the Uterus (INSITU); Deceased donor uterine retrieval, Publisher: WILEY, Pages: 76-76, ISSN: 1470-0328

Conference paper

Bayar E, 2023, Fertility preservation and realignment in transgender women, Human Fertility: an international, multidisciplinary journal dedicated to furthering research and promoting good practice, ISSN: 1464-7273

Medical care for transgender people is multi-faceted and attention to individual reproductiveaspirations and planning are an essential, yet often overlooked aspect of care. Given the impactof hormonal therapy and other gender affirmation procedures on reproductive function, extensivecounselling and consideration of fertility preservation is recommended prior to their commencement.This review article explores the reproductive aspirations of transgender women andconsiders the current disparity between stated desires regarding utilisation of fertility preservationservices. Current fertility preservation options and prospective treatments currently showingpromise in the research arena are explored.

Journal article

Vali S, Jones BP, Saso S, Smith JRet al., 2023, The impact of COVID-19 on the motivations of women seeking a uterus transplant, FUTURE SCIENCE OA, Vol: 9, ISSN: 2056-5623

Journal article

Mitra A, Verbakel JY, Kasaven LS, Tzafetas M, Grewal K, Jones B, Bennett PR, Kyrgiou M, Saso Set al., 2023, The menstrual cycle and the COVID-19 pandemic., PLoS One, Vol: 18

BACKGROUND: The impact of COVID-19 virus on menstrual cycles in unvaccinated women is limited. OBJECTIVE: To investigate the prevalence of changes to menstrual cycle characteristics, hormonal symptoms and lifestyle changes prior to and during the COVID-19 pandemic. METHODS: A retrospective online cross-sectional survey completed by social media users between July 2020 to October 2020. Participants were living in the United Kingdom (UK), premenopausal status and, or over 18 years of age. MAIN OUTCOME(S) AND MEASURES(S): The primary outcome was to assess changes to menstrual cycle characteristics during the pandemic following the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). Secondary outcomes included assessment of hormonal and lifestyle changes. RESULTS: 15,611 social media users completed the survey. Of which, 75% of participants experienced a change in their menstrual cycle, with significantly greater proportions reporting irregular menstrual cycles (P<0·001), bleeding duration more than seven days (P<0·001), longer mean cycle length (P<0·001) and overall bleeding duration (P<0·001). Over half the participants reported worsening of premenstrual symptoms including low mood/depression, anxiety and irritability. When stratified according to COVID-19 infection, there was no significant difference in menstrual cycle changes. CONCLUSION: The COVID-19 pandemic resulted in considerable variation in menstrual cycle characteristics and hormonal symptoms. This appears to be related to societal and lifestyle changes resulting from the pandemic, rather than to the virus itself. We believe this may have an impact on the individual, as well as national economy, healthcare, and population levels, and therefore suggest this should be taken into consideration by governments, healthcare providers and employers when developing pandemic recovery plans.

Journal article

Currie JLD, Saso S, Guerrero K, Davies Met al., 2022, Impact of covid-19 on subspecialty training in obstetrics and gynaecology, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol: 42, Pages: 3545-3551, ISSN: 0144-3615

Journal article

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.

Request URL: http://wlsprd.imperial.ac.uk:80/respub/WEB-INF/jsp/search-html.jsp Request URI: /respub/WEB-INF/jsp/search-html.jsp Query String: respub-action=search.html&id=00330574&limit=30&person=true